| association id |
FEATURE |
Drug id |
Propr |
Public |
Drug Name |
Drug Target |
N FEATURE pos |
N FEATURE neg |
log max Conc tested |
FEATURE neg logIC50 MEAN |
FEATURE pos logIC50 MEAN |
FEATURE deltaMEAN IC50 |
FEATURE IC50 effectSize |
FEATURE neg Glass delta |
FEATURE pos Glass delta |
ANOVA FEATURE pval |
Tissue ANOVA pval |
MSI ANOVA pval |
ANOVA FEATURE FDR % |
a17 |
CDKN1B_mut |
1009 |
1 |
1 |
ATRA |
Retinoic acid and retinoid X receptor agonist |
5 |
832 |
2.3 |
3.92 |
0.0304 |
-3.89 |
3 ** |
3.1 ** |
1.4 * |
2.9e-10 |
3.35e-32 |
2.03e-01 |
0.00028 |
a191 |
gain_cnaPANCAN280_(ARID4B,FH) |
1009 |
1 |
1 |
ATRA |
Retinoic acid and retinoid X receptor agonist |
51 |
786 |
2.3 |
3.85 |
4.63 |
0.776 |
0.6 . |
0.59 . |
0.92 . |
7.31e-05 |
4.12e-31 |
2.1e-01 |
6.3 |
a228 |
loss_cnaPANCAN293 |
1009 |
1 |
1 |
ATRA |
Retinoic acid and retinoid X receptor agonist |
16 |
821 |
2.3 |
3.88 |
4.8 |
0.911 |
0.7 . |
0.69 . |
1.2 * |
1.22e-04 |
4.55e-31 |
2.1e-01 |
8.8 |
a344 |
gain_cnaPANCAN236 |
1009 |
1 |
1 |
ATRA |
Retinoic acid and retinoid X receptor agonist |
9 |
828 |
2.3 |
3.91 |
2.65 |
-1.26 |
0.97 . |
0.98 . |
0.48 |
3.37e-04 |
5.54e-31 |
2.11e-01 |
16 |
a356 |
loss_cnaPANCAN290 |
1009 |
1 |
1 |
ATRA |
Retinoic acid and retinoid X receptor agonist |
14 |
823 |
2.3 |
3.88 |
4.92 |
1.03 |
0.79 . |
0.79 . |
2 ** |
3.62e-04 |
5.62e-31 |
2.11e-01 |
17 |
